IP Library › Assignment 032514/0901
Patent Assignment
Reel/Frame 032514/0901

Assignment of Assignor's Interest

Recorded: 2014-03-25 Pages: 3
Assignor
SOLTANI, NEPTON
Executed: 2010-12-19
Assignee
WANG, QINGHUA
22 BOND AVENUE, TORONTO, M3B 3R8, CANADA
Covered Property (1)
Pharmaceutical Composition for the Treatment of Type-1 Diabetes
Patent: 9,463,174 →
Application: 14/223,602 →
Publication: US 2014/0322213
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 28, 2020
From: WANG, QINGHUA
To: KUNMING INNOGEN PHARMACEUTICAL TECHNOLOGY CO., LTD.
Reel/Frame 054759/0655 →
Change of Name Oct 25, 2022
From: KUNMING INNOGEN PHARMACEUTICAL TECHNOLOGY CO., LTD.
To: GUANGZHOU INNOGEN PHARMCEUTICAL GROUP CO., LTD.
Reel/Frame 061767/0903 →
Corrective Assignment to Correct the Assignee Name Previously Recorded at Reel: 061767 Frame: 0903. Assignor(S) Hereby Confirms the Change of Name. Jan 4, 2023
From: KUNMING INNOGEN PHARMACEUTICAL TECHNOLOGY CO., LTD.
To: GUANGZHOU INNOGEN PHARMACEUTICAL GROUP CO., LTD.
Reel/Frame 062273/0483 →